Top Markets
#1 Siren Siren +33.55%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.97%
#3 Ribbita by Virtuals Ribbita by Virtuals +18.33%
#4 Wiki Cat Wiki Cat +17.15%
#5 PulseChain PulseChain +16.92%
#6 Velvet Velvet +16.44%
#7 Cysic Cysic +16.42%
#8 Bitway Bitway +16.08%
#9 KUB Coin KUB Coin +15.73%
#10 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +15.35%
Coin of the day
Siren Siren
設定
言語
日本
通貨
USD
テーマ
NeuroSense Therapeutics Ltd. NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd.

NRSN
株式のランク #31255
NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical... NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical development phase, committed to discovering and developing effective therapies for individuals suffering from severe neurodegenerative conditions. The company's leading drug candidate, PrimeC, is an innovative oral formulation that has successfully concluded Phase IIa clinical investigations for the management of amyotrophic lateral sclerosis (ALS). Additionally, its early-stage research pipeline features StabiliC, a potential treatment for Parkinson's disease, and CogniC, which is under development for Alzheimer's disease. Established in 2017, NeuroSense Therapeutics Ltd. is headquartered in Herzliya, Israel.
株価
$0.39
時価総額
$13.79M
変化（1日）
-13.53%
変化（1年）
-68.80%
国
IL
取引 NeuroSense Therapeutics Ltd. (NRSN)

カテゴリー

Healthcare
NeuroSense Therapeutics Ltd.（NRSN）の利益
2026 時点の利益 TTM: 0
NeuroSense Therapeutics Ltd. の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
NeuroSense Therapeutics Ltd. の利益の推移（2026 〜 2026）
各年末の利益
年 利益 変化
提供された日付のデータは十分ではありません。
同業他社の利益
企業 利益 利益の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE